Sodium (3alpha,5beta,6alpha)-3,6-dihydroxycholan-24-oate(CAS: 10421-49-5)

Sodium (3alpha,5beta,6alpha)-3,6-dihydroxycholan-24-oate (CAS: 10421-49-5) is subject to the European Union's REACH regulations, which require manufacturers and importers to register the substance with the European Chemicals Agency. Additionally, it is classified under the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) and may be regulated by the EPA in the United States and FDA for pharmaceutical applications, with specific handling and reporting requirements.

In the synthesis of related bile acids, there are alternative reagents and synthetic routes that can be used, such as ursodeoxycholic acid or cholic acid. These compounds serve as effective precursors for synthesizing analogs through traditional methods like condensation reactions and enzymatic transformations, providing flexibility in the design of new compounds.

The market for Sodium (3alpha,5beta,6alpha)-3,6-dihydroxycholan-24-oate (CAS: 10421-49-5) is driven by its applications in pharmaceuticals and research, particularly in the development of bile acid-related drugs. Recent research trends focus on understanding its pharmacological properties and exploring its potential in treating liver diseases and metabolic disorders. Prices fluctuate based on supply and demand, with increasing interest in its use as a functional food ingredient and in cosmeceuticals.

Waste containing Sodium (3alpha,5beta,6alpha)-3,6-dihydroxycholan-24-oate (CAS: 10421-49-5) should be collected in sealed containers and disposed of through professional waste disposal services. Incineration is a common method for disposal, ensuring complete destruction of the substance. Environmental protection measures include minimizing the risk of contamination during handling and disposal, adhering to local and international environmental regulations, and utilizing safe transport methods to prevent spills or leaks.